Clinical Trial Update: ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ICMNC-HF, investigating intra-coronary bone marrow mononuclear cells in heart failure patients (Phase 1/Phase 2). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• IntraCoronary Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: SCARM Institute, Tabriz, Iran | Conditions: Heart Failure | Phase 1, Phase 2 | Status: UNKNOWN